World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
34770
World Ranking
11648
National Ranking
61

Richard Pötter publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard Pötter sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 641 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard Pötter D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Pötter sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Richard Pötter is affiliated with the Medical University of Vienna in Austria. Their research primarily spans the field of Medicine, with a significant focus on Obstetrics and Gynecology. Their academic output includes notable contributions to the study and treatment of gynecologic cancers and advanced radiotherapy techniques.

The main topics covered by their work include:

  • Endometrial and Cervical Cancer Treatments
  • Cervical Cancer and HPV Research
  • Management of metastatic bone disease
  • Ovarian cancer diagnosis and treatment
  • Advanced Radiotherapy Techniques
  • Gastric Cancer Management and Outcomes
  • Cancer survivorship and care

Pötter has published extensively in prominent journals. Frequent publication venues include:

  • Radiotherapy and Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • International Journal of Gynecological Cancer
  • Brachytherapy
  • Strahlentherapie und Onkologie

Important recent papers authored or co-authored by Pötter are:

  • MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study, 2021, The Lancet Oncology
  • Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial, 2020, The Lancet Oncology
  • Image guidance in radiation therapy for better cure of cancer, 2020, Molecular Oncology
  • Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study, 2020, International Journal of Radiation Oncology*Biology*Physics
  • Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study, 2023, Journal of Clinical Oncology

Throughout their career, Pötter has collaborated frequently with other researchers in the field. Their frequent co-authors are:

  • Kari Tanderup
  • Christian Kirisits
  • Alina Sturdza
  • Remi A. Nout
  • Maximilian Schmid

Best Publications

  • Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.

    Richard Pötter;Christine Haie-Meder;Erik Van Limbergen;Isabelle Barillot

  • Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV

    Christine Haie-Meder;Richard Pötter;Erik Van Limbergen;Edith Briot

  • Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.

    Richard Pötter;Petra Georg;Johannes C.A. Dimopoulos;Magdalena Grimm

  • The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies

    Richard Pötter;Kari Tanderup;Christian Kirisits;Astrid de Leeuw

  • Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)

    Csaba Polgár;Erik Van Limbergen;Richard Pötter;György Kovács

  • 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.

    Vratislav Strnad;Oliver J Ott;Guido Hildebrandt;Daniela Kauer-Dorner

  • The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.

    David Cibula;Richard Pötter;François Planchamp;Elisabeth Avall-Lundqvist

  • Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.

    Alina Sturdza;Richard Pötter;Lars Ulrik Fokdal;Christine Haie-Meder

  • Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.

    Richard Pötter;Johannes Dimopoulos;Petra Georg;Stefan Lang

  • Computed Tomography Versus Magnetic Resonance Imaging-Based Contouring in Cervical Cancer Brachytherapy: Results of a Prospective Trial and Preliminary Guidelines for Standardized Contours

    Akila N. Viswanathan;Johannes Dimopoulos;Christian Kirisits;Daniel Berger

  • Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience.

    Tadashi Kamada;Hirohiko Tsujii;Eleanor A Blakely;Jürgen Debus

  • Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy

    Johannes C.A. Dimopoulos;Peter K Petrow;Kari Tanderup;Primoz Petric

  • MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

    Richard Pötter;Kari Tanderup;Maximilian Paul Schmid;Ina Jürgenliemk-Schulz

  • Dose and volume parameters for mri-based treatment planning in intracavitary brachytherapy for cervical cancer

    Christian Kirisits;Richard Pötter;Stefan Lang;Johannes Dimopoulos

  • The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.

    Christian Kirisits;Stefan Lang;Johannes Dimopoulos;Daniel Berger

  • Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.

    Kari Tanderup;Lars Ulrik Fokdal;Alina Sturdza;Christine Haie-Meder

  • High Cure Rates and Reduced Long-Term Toxicity in Pediatric Hodgkin's Disease: The German-Austrian Multicenter Trial DAL-HD-90

    Günther Schellong;Richard Pötter;Jürgen Brämswig;Wolfgang Wagner

  • Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study.

    Lars Fokdal;Alina Sturdza;Renaud Mazeron;Christine Haie-Meder

  • Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.

    Johannes C.A. Dimopoulos;Stefan Lang;Christian Kirisits;Elena F. Fidarova

  • Dose–effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy

    Johannes C.A. Dimopoulos;Richard Pötter;Stefan Lang;Elena Fidarova

Frequent Co-Authors

Peter Hoskin
Peter Hoskin University of Manchester
Christine Haie-Meder
Christine Haie-Meder Institut Gustave Roussy
Erich Minar
Erich Minar Medical University of Vienna
Wolfgang Uter
Wolfgang Uter University of Erlangen-Nuremberg
Rainer Fietkau
Rainer Fietkau University of Erlangen-Nuremberg
Søren M. Bentzen
Søren M. Bentzen University of Maryland, Baltimore
Jürgen Debus
Jürgen Debus University Hospital Heidelberg
Roberto Orecchia
Roberto Orecchia European Institute of Oncology
Thomas H. Helbich
Thomas H. Helbich Medical University of Vienna
Christine M. Gall
Christine M. Gall University of California, Irvine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine isn't limited to traditional medical school. There are numerous online ADN programs for non nurses that provide flexible opportunities for those looking to start a nursing career, even if you haven't completed previous nursing coursework.

For those interested in the administrative side of healthcare, consider studying through the best online medical billing and coding schools. These programs prepare students for vital roles handling patient data and insurance claims, and many offer financial aid options.

Not every nursing school requires standardized tests. Some institutions have adapted to modern admissions by providing access to programs at the do all nursing schools require the teas level, making the entry process less stressful for prospective students.

If you're aiming for leadership roles, an accelerated healthcare administration degree online can help you fast-track your education and prepare for in-demand positions in hospitals, clinics, and healthcare organizations.

Best Scientists Citing Richard Pötter

Trending Scientists

Recently Published Articles